Stay updated on Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.

Latest updates to the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page footer displays a new Revision: v3.6.6, replacing the previous v3.6.5, indicating a small update to the page.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor maintenance update. The core study details and user-facing content appear unchanged.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page footer now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating the current page build. This is a minor version update that tracks the latest iteration of the page rather than altering its content.SummaryDifference0.1%

- Check65 days agoChange DetectedStudy status updated to Completed and the Study Completion (Actual) date shown as 2026-03-09. The previous Active, not recruiting label and its related values were removed.SummaryDifference0.4%

- Check72 days agoChange DetectedThe study documents reference has been updated to revision v3.6.3, replacing the previous v3.6.2. This indicates the trial materials have been refreshed to the latest revision.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2. This indicates a new version of the page content, typically reflecting backend updates or minor edits, without changing the study details displayed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.